Nu-Med Plus (NUMD) Net Income Growth (5y) (2017 - 2025)
Nu-Med Plus (NUMD) Net Income Growth (5y) (2017 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.26 Bn | 175.96 Bn | 6.27 Bn |
| 2 | Stryker | 128.79 Bn | 125.92 Bn | 3.81 Bn |
| 3 | Medtronic | 108.56 Bn | 99.34 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.31 Bn | 66.86 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 47.27 Bn | 43.60 Bn | 1.29 Bn |
| 6 | Dexcom | 28.42 Bn | 27.31 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.40 Bn | 26.12 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.95 Bn | 26.37 Bn | - |
| 9 | Koninklijke Philips | 25.52 Bn | 22.40 Bn | 2.07 Bn |
| 10 | Nu-Med Plus | 1.67 Mn | 1.67 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 52.24% |
| Sep 30, 2025 | 51.67% |
| Jun 30, 2025 | 58.15% |
| Mar 31, 2025 | 33.85% |
| Dec 31, 2024 | 46.43% |
| Sep 30, 2024 | 34.13% |
| Jun 30, 2024 | 40.88% |
| Mar 31, 2024 | 44.98% |
| Dec 31, 2023 | 29.02% |
| Sep 30, 2023 | 49.85% |
| Jun 30, 2023 | 31.72% |
| Mar 31, 2023 | 27.16% |
| Dec 31, 2022 | 18.49% |
| Sep 30, 2022 | 15.22% |
| Jun 30, 2022 | 11.43% |
| Mar 31, 2022 | 1.95% |
| Dec 31, 2021 | -48.60% |
| Sep 30, 2021 | 29.72% |
| Jun 30, 2021 | -7.88% |
| Mar 31, 2021 | -42.77% |